NEU 0.46% $19.30 neuren pharmaceuticals limited

Development in many indications can be still be done without...

  1. 2,374 Posts.
    lightbulb Created with Sketch. 739
    Development in many indications can be still be done without needing a takeover. Indications can be licenced exactly as trof was for Retts, so assuming a takeover is required in 'best interests of all stakeholders' is not correct. Nor is your assumptions RE management.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.30
Change
-0.090(0.46%)
Mkt cap ! $2.466B
Open High Low Value Volume
$19.55 $19.65 $18.88 $10.53M 549.5K

Buyers (Bids)

No. Vol. Price($)
4 4552 $19.15
 

Sellers (Offers)

Price($) Vol. No.
$19.30 674 2
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.